EMPE Diagnostics has been recognised by SwedenBIO and has become a part of the Swedish Precision Medicine Industry Landscape.

Posted Posted in Uncategorized

We are overwhelmed for the recognition by SwedenBIO that launched the Precision Medicine – The Swedish Industry Guide 2018! SwedenBIO has launched a major new report representing the first effort to map the Swedish Precision Medicine Industry Landscape and showcase precision medicine companies in Sweden to the global life science community.

Going to India: Participation in InnoHealth 2017

Posted Posted in Uncategorized

InnoHEALTH 2017 is the second in the series of InnoHEALTH annual conferences in India, building on the success of InnoHEALTH 2016 which saw 200 participants from the World Health Innovation Network, Canada, Talent grid Ventures, Singapore, ScanBalt Forum, and Europe. The focus of this conference is to bring together the ‘innovations in healthcare’. EMPE Diagnostics […]

Joining the Central Baltic Health Access and Swecare

Posted Posted in Uncategorized

Swecare is a Swedish Govt. initiative that helps interactions between academia and public and private sectors, to join forces toward enhanced export and internationalization of Swedish health care and life sciences. EMPE Diagnostics is the only Molecular Diagnostic company among 9 companies that were selected to participate in the Central Baltic Health Access initiated by […]

Partnering with Q-linea

Posted Posted in Uncategorized

We are happy to announce that EMPE Diagnostics is partnering with the Swedish company, Q-linea AB who has years of experience in developing rapid diagnostics! Q-linea’s fully automated solutions cut the diagnostic time for sepsis and deliver clinically-actionable results in hours instead of days.